MA
IDXG

Minerva Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Minerva Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-222
Closed -$41K – 75
2015
Q3 		$41K Hold
222
– – 0.03% 74
2015
Q2 		$31K Hold
222
– – 0.02% 72
2015
Q1 		$30K Hold
222
– – 0.02% 71
2014
Q4 		$40K Hold
222
– – 0.02% 76
2014
Q3 		$53K Buy
222
+88
+66% +$29.4K 0.03% 73
2014
Q2 		$59K Buy
134
+33
+33% +$15.2K 0.03% 76
2014
Q1 		$46K Buy
+101
New +$52.5K 0.03% 76

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Minerva Advisors's IDXG Position: Q4 2015 in Review

Minerva Advisors sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2015, closing a stake of 222 shares — an estimated $41K sold.

Minerva Advisors first reported a position in IDXG in Q1 2014 and held it in 7 quarters. The position peaked at $59K in Q2 2014. 19 funds tracked by Wall St. Rank hold IDXG as of Q4 2015.

  • Minerva Advisors reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Minerva Advisors sold 222 Interpace Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $41K.
  • Minerva Advisors first reported a position in Interpace Biosciences, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
  • Minerva Advisors's Interpace Biosciences, Inc. Common Stock position peaked at $59K in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2015.

Based on Minerva Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.